| ||
Pharma industry projected to grow 18 per cent by 2016-17: Government Economic Times "According to the Report of the Working Group on Drugs and Pharmaceuticals Industry for XII Five Year Plan, the projected rate of growth for Indian Pharmaceutical industry is envisaged as 18 per cent by 2016-17," Minister of State for Chemicals and ... See all stories on this topic » | ||
Pharmaceutical Group Set For 20% Growth Motley Fool UK Hikma Pharmaceuticals (LSE: HIK) soared 42p, or 6% to 767p, in early London trading after the pharmaceutical specialist published its half-year results. Hikma reported six-month sales up 35% to $532 million and adjusted profits up 37% to $82 million. See all stories on this topic » | ||
| ||
Pharma council seeks changes to tax laws on export credit Economic Times HYDERABAD: The Pharmaceutical Export Promotion Council has written to the ministries of commerce and finance to amend tax laws with respect to export credit granted to Indian pharma companies. The export credit of 5.5% available to pharma companies ... See all stories on this topic » | ||
Watson sues FDA on generic diabetes drug ruling Chicago Tribune (Reuters) - Generic drugmaker Watson Pharmaceuticals Inc sued the U.S. Food and Drug Administration, challenging a ruling against Watson's generic version of a big-selling diabetes drug, Actos. Watson said that the FDA improperly denied the company's ... See all stories on this topic » | ||
Prices of patented medicines may come down by a third if panel's ... Economic Times NEW DELHI: An inter-ministerial group tasked with regulating prices of patented medicines has recommended using a per capita income-linked reference pricing mechanism, a proposal that may reduce prices of several patented drugs by up to one-third but ... See all stories on this topic » | ||
TG Therapeutics and Rhizen Pharmaceuticals Announce Global Agreement for ... NASDAQ 16, 2012 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (TG Therapeutics) (OTCBB:TGTX) and Rhizen Pharmaceuticals S A (Rhizen) today announced that the companies have entered into an exclusive global agreement to collaborate on the development ... See all stories on this topic » | ||
Tonix Pharmaceuticals CEO Dr. Seth Lederman Describes Potential Treatment ... 4-traders Seth Lederman, M.D., President and CEO of New York City-based Tonix Pharmaceuticals Holding Corp. ("TONIX" or the "Company") (OTCBB:TNXP) says that a good night's sleep is a potentially powerful, but currently elusive, treatment for the chronic pain ... See all stories on this topic » | ||
iPad Use Is on the Rise in Pharmaceutical Sales Pitches: Study eWeek The Apple iPad tablet is a key part of a pharmaceutical sales representative's toolkit, a new study by Manhattan Research confirmed. Among "ePharma" doctors who met with pharmaceutical salespeople face to face, 65 percent reported that the ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment